Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater
出版年份 2019 全文链接
标题
Distinct immunological properties of the two histological subtypes of adenocarcinoma of the ampulla of Vater
作者
关键词
Adenocarcinoma of the ampulla of Vater, PD-L1, CD8 T lymphocytes, YAP, Prognosis, Immunohistochemistry
出版物
CANCER IMMUNOLOGY IMMUNOTHERAPY
Volume -, Issue -, Pages -
出版商
Springer Nature
发表日期
2019-01-02
DOI
10.1007/s00262-018-02293-6
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- YAP-Induced PD-L1 Expression Drives Immune Evasion in BRAFi-Resistant Melanoma
- (2018) Min Hwan Kim et al. Cancer Immunology Research
- Single tumor-initiating cells evade immune clearance by recruiting type II macrophages
- (2017) Xiaocan Guo et al. GENES & DEVELOPMENT
- Tumor cell expression of immune inhibitory molecules and tumor-infiltrating lymphocyte count predict cancer-specific survival in pancreatic and ampullary cancer
- (2017) Kostandinos Sideras et al. INTERNATIONAL JOURNAL OF CANCER
- Tumor cell-derived lactate induces TAZ-dependent upregulation of PD-L1 through GPR81 in human lung cancer cells
- (2017) J Feng et al. ONCOGENE
- PD-L1: a novel prognostic biomarker in head and neck squamous cell carcinoma
- (2017) Tim Müller et al. Oncotarget
- Role of YAP/TAZ transcriptional regulators in resistance to anti-cancer therapies
- (2016) Min Hwan Kim et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- YAP1 and TAZ Control Pancreatic Cancer Initiation in Mice by Direct Up-regulation of JAK–STAT3 Signaling
- (2016) Ralph Gruber et al. GASTROENTEROLOGY
- Mechanisms of tumor escape in the context of the T-cell-inflamed and the non-T-cell-inflamed tumor microenvironment
- (2016) Stefani Spranger INTERNATIONAL IMMUNOLOGY
- Validation of histomolecular classification utilizing histological subtype, MUC1 and CDX2 for prognostication of resected ampullary adenocarcinoma
- (2015) A Schueneman et al. BRITISH JOURNAL OF CANCER
- Classifying Cancers Based on T-cell Infiltration and PD-L1
- (2015) Michele W.L. Teng et al. CANCER RESEARCH
- Hippo Pathway in Organ Size Control, Tissue Homeostasis, and Cancer
- (2015) Fa-Xing Yu et al. CELL
- 525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028
- (2015) Y.J. Bang et al. EUROPEAN JOURNAL OF CANCER
- Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer
- (2015) Kurt A. Schalper et al. JNCI-Journal of the National Cancer Institute
- Nivolumab in Previously Untreated Melanoma without BRAF Mutation
- (2015) Caroline Robert et al. NEW ENGLAND JOURNAL OF MEDICINE
- PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
- (2015) Dung T. Le et al. NEW ENGLAND JOURNAL OF MEDICINE
- Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
- (2015) Edward B. Garon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer
- (2015) N. A. Rizvi et al. SCIENCE
- Targeting YAP-Dependent MDSC Infiltration Impairs Tumor Progression
- (2015) G. Wang et al. Cancer Discovery
- YAP is a critical oncogene in human cholangiocarcinoma
- (2015) Tiemin Pei et al. Oncotarget
- Objective Measurement and Clinical Significance of TILs in Non–Small Cell Lung Cancer
- (2015) Kurt A. Schalper et al. JNCI-Journal of the National Cancer Institute
- The Utility of Immunohistochemistry in Subtyping Adenocarcinoma of the Ampulla of Vater
- (2014) Daphne C. Ang et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics
- (2014) D. Massi et al. ANNALS OF ONCOLOGY
- PD-1 blockade induces responses by inhibiting adaptive immune resistance
- (2014) Paul C. Tumeh et al. NATURE
- Overexpression of YAP 1 contributes to progressive features and poor prognosis of human urothelial carcinoma of the bladder
- (2013) Jian-Ye Liu et al. BMC CANCER
- Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer
- (2013) B Goeppert et al. BRITISH JOURNAL OF CANCER
- Histomolecular Phenotypes and Outcome in Adenocarcinoma of the Ampulla of Vater
- (2013) David K. Chang et al. JOURNAL OF CLINICAL ONCOLOGY
- Programmed death-ligand 1 (PD-L1) expression in various tumor types
- (2013) Joseph Grosso et al. Journal for ImmunoTherapy of Cancer
- Ampullary Region Carcinomas
- (2012) Volkan Adsay et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis
- (2011) M J M Gooden et al. BRITISH JOURNAL OF CANCER
- Tumor-Infiltrating CD8+ Lymphocytes Predict Clinical Outcome in Breast Cancer
- (2011) Sahar M.A. Mahmoud et al. JOURNAL OF CLINICAL ONCOLOGY
- Overexpression of yes-associated protein contributes to progression and poor prognosis of non-small-cell lung cancer
- (2010) Yang Wang et al. CANCER SCIENCE
- Overexpression of PD-L1 Significantly Associates with Tumor Aggressiveness and Postoperative Recurrence in Human Hepatocellular Carcinoma
- (2009) Q. Gao et al. CLINICAL CANCER RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now